Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin

[1]  A. Barry,et al.  Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin. , 1991, The Journal of antimicrobial chemotherapy.

[2]  A. Pablos-Mendez,et al.  Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital , 1990, Antimicrobial Agents and Chemotherapy.

[3]  P. Rapoza,et al.  Keratitis associated with Pseudomonas mesophilica in a patient taking topical corticosteroids. , 1990, American journal of ophthalmology.

[4]  F. K. Gould,et al.  Successful treatment with chloramphenicol of Pseudomonas mesophilica peritonitis not responding to aztreonam and gentamicin. , 1990, The Journal of antimicrobial chemotherapy.

[5]  M. Terpenning,et al.  Increasing resistance of Staphylococcus aureus to ciprofloxacin , 1990, Antimicrobial Agents and Chemotherapy.

[6]  R. Jones,et al.  In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents. , 1989, The Journal of antimicrobial chemotherapy.

[7]  I. Shalit,et al.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital , 1989, Antimicrobial Agents and Chemotherapy.

[8]  M. Peel,et al.  Peritonitis caused by Pseudomonas mesophilica in a patient undergoing continuous ambulatory peritoneal dialysis , 1988, Journal of clinical microbiology.

[9]  R. R. Bower,et al.  Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones , 1987, Antimicrobial Agents and Chemotherapy.

[10]  Jones Rn,et al.  In vitro activity of ciprofloxacin against gram-positive cocci. , 1987 .

[11]  F. Kayser,et al.  In vitro activity of ciprofloxacin against gram-positive bacteria. An overview. , 1987, The American journal of medicine.

[12]  J. Almenoff,et al.  Clinical significance of serum thermolysin-like metalloendopeptidase and its relationship to serum angiotensin converting enzyme in sarcoidosis. , 1987, The American journal of medicine.

[13]  R. Jones,et al.  In vitro activity of ciprofloxacin against gram-positive cocci. , 1987, The American journal of medicine.

[14]  M. Gilchrist,et al.  Detection of Pseudomonas mesophilica as a source of nosocomial infections in a bone marrow transplant unit , 1986, Journal of clinical microbiology.

[15]  R. Eng,et al.  Pseudomonas mesophilica infections in humans , 1985, Journal of clinical microbiology.

[16]  P. Welling,et al.  Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers , 1984, Antimicrobial Agents and Chemotherapy.

[17]  Y. Fâur,et al.  Pseudomonas mesophilica and an unnamed taxon, clinical isolates of pink-pigmented oxidative bacteria , 1984, Journal of clinical microbiology.

[18]  R. Wise,et al.  Pharmacokinetics and tissue penetration of ciprofloxacin , 1983, Antimicrobial Agents and Chemotherapy.

[19]  M. Rinaldi.  Use of potato flakes agar in clinical mycology , 1982, Journal of clinical microbiology.

[20]  M. Goodfellow,et al.  Pseudomonas mesophilica, a New Species of Pink Bacteria Isolated from Leaf Surfaces , 1979 .

[21]  M. Goodfellow,et al.  Quantitative and Qualitative Studies of Phylloplane Bacteria from Lolium perenne , 1975 .

[22]  D. Louria,et al.  AN INTERESTING MICROORGANISM RECOVERED FROM THREE PATIENTS WITH SYSTEMIC DISEASE. , 1964, American Review of Respiratory Disease.